217 studies found for:
"Ewing sarcoma"
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Recruiting |
Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma
|
||||
| 2 | Recruiting |
18F-FLT Positron Emission Tomography and Diffusion-Weighted Magnetic Resonance Imaging in Planning Surgery and Radiation Therapy and Measuring Response in Patients With Newly Diagnosed Ewing Sarcoma
|
||||
| 3 | Not yet recruiting |
Whole-Body Radiation Therapy, Systemic Chemotherapy, and High-Dose Chemotherapy Followed By Stem Cell Rescue in Treating Patients With Poor-Risk Ewing Sarcoma
|
||||
| 4 | Completed |
Two Regimens of Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed Localized Ewing Sarcoma Family of Tumors
|
||||
| 5 | Recruiting |
Genetic Biomarkers in Saliva Samples From Patients With Ewing Sarcoma
|
||||
| 6 | Completed |
Study of Zalypsis® (PM00104) in Patients With Unresectable Locally Advanced and/or Metastatic Ewing Family of Tumors (EFT) Progressing After at Least One Prior Line of Chemotherapy
|
||||
| 7 | Completed |
A Five-Tier, Open-Label Study of IMC-A12 in Advanced Sarcoma
|
||||
| 8 | Completed |
Tanespimycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid Tumors
|
||||
| 9 | Completed |
Trabectedin in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of Tumors
|
||||
| 10 | Recruiting |
Dasatinib and Ipilimumab in Treating Patients With Gastrointestinal Stromal Tumors or Other Sarcomas That Cannot be Removed by Surgery or Are Metastatic
|
||||
| 11 | Active, not recruiting |
Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor
|
||||
| 12 | Recruiting |
Intensity-Modulated Radiation Therapy in Treating Younger Patients With Lung Metastases
|
||||
| 13 | Completed |
Sorafenib in Treating Patients With Soft Tissue Sarcomas (Extremity Sarcoma Closed to Entry as of 5/30/07)
|
||||
| 14 | Completed |
17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma
|
||||
| 15 | Recruiting |
Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma
|
||||
| 16 | Active, not recruiting |
Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma
|
||||
| 17 | Completed |
IMC-A12 in Treating Young Patients With Relapsed or Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor or Other Solid Tumor
|
||||
| 18 | Active, not recruiting |
A Study to Determine the Activity of SCH 717454 in Subjects With Relapsed Osteosarcoma or Ewing's Sarcoma (Study P04720AM5)
|
||||
| 19 | Recruiting |
Study in Localized and Disseminated Ewing Sarcoma
|
||||
| 20 | Recruiting |
Mithramycin for Children and Adults With Solid Tumors or Ewing Sarcoma
|
† Indicates status has not been verified in more than two years
